Why are cancer centers across Europe applying for INTERACT-EUROPE 100 – European Cancer Organisation

European Cancer Organisation shared a post on LinkedIn:

”Why are cancer centers across Europe applying for INTERACT-EUROPE 100?

We asked our applicants why inter-specialty cancer training is so important to them.

See what Associate Professor Ann Hopkins, Scientific Director Professor Roberto Orecchia and Dr. Deborah Moreno-Alonso have to say; and join them in the next step of multidisciplinary cancer care.

Sign up today!”

View attached video.
Source: European Cancer Organisation/LinkedIn

Ann Hopkins is an Associate Professor at RCSI University of Medicine and Health Sciences and the Education Lead at Beaumont RCSI Cancer Centre. Her research focuses on translational cancer biology, specifically investigating how altered epithelial cell-cell and cell-matrix adhesion contribute to the initiation and progression of breast cancer.

Roberto Orecchia is the Head of Medical Imaging and Radiation Sciences and Scientific Director at the European Institute of Oncology (IEO) in Milan. He was formerly the Scientific Director at the National Center of Oncological Hadrontherapy (CNAO) and is now a member of its Scientific Board. His work focuses on innovation in radiotherapy and oncology.

Deborah Moreno-Alonso is the Head of the Learning Ecosystem Unit at the Catalan Institute of Oncology (ICO) and leads the e-oncology program. She is also a collaborating professor at both the International University of La Rioja (UNIR) and the International University of Catalonia. Additionally, she serves as a postdoctoral researcher with the WeCare Chair, focusing on palliative care.